Supporting Resilience and the Management of Grief and Loss among Nurses:Qualitative Themes from a Continuing Education Program / 한국호스피스완화의료학회지

Caring for patients with cancer is highly stimulating and rewarding, attracting health professionals to the field who enjoy the challenge of managing a complex illness. Health professionals often form close bonds with their patients as they confront ongoing disease or treatment impacts, which may be associated with multiple losses involving function and/or eventual loss of life. Ongoing exposure to patient loss, along with a challenging work setting, may pose significant stress and impact health professionals’ well-being. The prevalence rates of burnout and compassion fatigue (CF) are significant, yet health professionals have little knowledge on these topics. A 6-week continuing education program consisting of weekly small-group video-conferencing sessions, case-based learning, and an online community of practice was delivered to health care providers providing oncology care. Program content included personal, organization and team-related risk and protective factors associated with CF, grief models, and strategies to mitigate against CF. Content analysis was completed as part of the program evaluation. In total, 189 participants (93% nurses) completed the program, which was associated with significant improvements in confidence and knowledge of CF and strategies to support self and team resilience. Qualitative themes and vignettes from experiences with the program are presented. Key themes included knowledge gaps, a lack of support related to CF and strategies to support resilience, organizationand team-based factors that can inhibit expression about the impacts of clinical work, the health professional as a “person” in caregiving, and the role of personal variables, self-skill practices, and recommendations for education and support for self and teams.

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster the exchange of ideas and stimulate new collaborative interactions among leading cancer prevention researchers from basic and clinical research; highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials; and provide information to the extramural research community on the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials. The meeting included two plenary talks and five sessions covering the range from pre-clinical studies with chemo/immunopreventive agents to ongoing cancer prevention clinical trials. In addition, two NCI informational sessions describing contract resources for the preclinical agent development and cooperative grants for the Cancer Prevention Clinical Trials Network were also presented.

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored the Translational Advances in Cancer Prevention Agent Development Meeting on August 27 to 28, 2020. The goals of this meeting were to foster the exchange of ideas and stimulate new collaborative interactions among leading cancer prevention researchers from basic and clinical research; highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials; and provide information to the extramural research community on the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials. The meeting included two plenary talks and five sessions covering the range from pre-clinical studies with chemo/immunopreventive agents to ongoing cancer prevention clinical trials. In addition, two NCI informational sessions describing contract resources for the preclinical agent development and cooperative grants for the Cancer Prevention Clinical Trials Network were also presented.

Impacto socioeconómico de la variabilidad climática en pesca y turismo: antecedentes y propuesta metodológica

Introducción: La variabilidad climática tiene efectos importantes sobre las diferentes actividades económicas que se desarrollan en zonas costeras y que emplean servicios ecosistémicos para su funcionamiento. Actualmente, no existen metodologías integrales que permitan realizar un proceso de valoración teniendo en cuenta todas las variables y las interacciones entre ellas. Objetivo: Proponer una aproximación metodológica que incluya de manera integral las diferentes etapas en el proceso de valoración económica de servicios ecosistémicos en zonas costeras, ante la variabilidad climática. Métodos: Se realizó una revisión bibliográfica, consulta a expertos y se empleó un ejemplo de aplicación usando la actividad turística de buceo con tiburones martillos en la Isla del Coco. Resultados: La aproximación metodológica propuesta inicia con la caracterización socioeconómica y ambiental de la actividad que emplea el recurso natural como insumo, posteriormente se realiza una identificación y caracterización de las variables ambientales que afectan el recurso natural y los efectos que la variación de este recurso tiene sobre la actividad económica. Conclusiones: Las variables que conforman el sistema climático, que tienen relación con los recursos naturales y las actividades económicas, al ser influenciadas por fenómenos externos, producen efectos que deben ser analizados por medio de aproximaciones metodológicas integrales, dentro de las cuales uno de los pasos es la metodología de valoración, que permitan generar recomendaciones de política que contribuyan a minimizar esos efectos.

Introduction: Climate variability has important effects on the different economic activities that take place in marine areas. Currently, there are no comprehensive methodologies to carry out an assessment process that consider all the variables and interactions between them. Objective: To propose a methodological approach that comprehensively includes the different stages in the process of economic valuation of ecosystem services in coastal areas, in the face of climate variability. Methods: A bibliographic review, expert consultations and an application of a methodological example using the impact over shark diving activities at Isla del Coco were conducted. Results: The proposed methodological approach begins with the socio-economic and environmental characterization of the activity that uses a natural resource as input, followed by the identification and characterization of the environmental variables that affect the natural resource and of the effects that the variation of this resource has on the economic activity. Conclusions: The variables that make up the climate system, which relate to natural resources and economic activities, being influenced by external phenomena, produce effects that must be analyzed by comprehensive methodological approximations, within which one of the steps is the valuation methodology, that will allow generating policy recommendations that help to minimize these effects.

Desempeño de la presepsina como biomarcador temprano de sepsis en un hospital de alta complejidad en Medellín, Colombia / Performance of presepsin as early biomarker of sepsis in a high complexity hospital from Medellin, Colombia

Introducción: la presepsina es el subtipo soluble de la glicoproteína CD14 expresada en la superficie de membrana de los monocitos y los macrófagos; molécula importante en el proceso inflamatorio. Varios estudios sugieren realizar su medición para la identificación temprana de la sepsis. Objetivo: determinar el desempeño diagnóstico y pronóstico de la presepsina en pacientes con sepsis clínica de un hospital de alta complejidad en Medellín, Colombia. Materiales y métodos: se realizó un estudio descriptivo prospectivo de cohorte única en 60 pacientes con diagnóstico de sepsis clínica durante marzo y diciembre de 2012. La presepsina se midió al momento del diagnóstico, a las 24 y 72 horas; la proteína C reactiva, la procalcitonina y el hemocultivo sólo al momento del diagnóstico. Se utilizaron herramientas de estadística descriptiva para la caracterización de la población y análisis bivariado para la comparación entre medianas. Resultados: El 98,3% de los pacientes tuvieron valores de presepsina sugestivos de sepsis, observándose un valor significativamente más alto en los pacientes sin mejoría (mayor que 700 pg/mL). Se observaron valores de presepsina mayores que 1.000 pg/mL a las 0 y 72 horas del diagnóstico en los pacientes que murieron, pero no se observaron diferencias significativas en comparación con los que no murieron. La proteína C reactiva y la procalcitonina mostraron valores aumentados en la mayoría de los pacientes. Conclusiones: los hallazgos de este estudio se relacionan con lo encontrado en otros estudios donde concluyen que la presepsina es un buen marcador de sepsis, con un importante valor pronóstico y mayor especificidad que otros biomarcadores tradicionales. Palabras clave: sepsis, biomarcadores, diagnóstico, antígenos CD14. (AU)

Introduction: Presepsin is the soluble form of CD14 molecule, a glycoprotein expressed on the membrane surface of monocytes and macrophages and important to inflammatory response. Several studies suggest that presepsin measuring could be used as a good tool to early sepsis diagnosis. Objective: To determine the diagnostic and prognostic performance of presepsin in patients with clinical sepsis at a high complexity hospital from Medellin, Colombia. Materials and methods: A prospective, descriptive cohort study was performed in 60 patients diagnosed with clinical sepsis between March and December of 2012. Presepsin measurement was made at diagnosis time and after 24 and 72 hours. Blood culture, C-reactive protein and procalcitonin were also measured but only at the diagnosis time. Results: 98.3% of patients had presepsin values suggestive of sepsis, with a significantly higher value in patients without clinical improvement (greater than 700 pg/mL). Presepsin values greater than 1,000 pg /mL at 0 and 72 hours of diagnosis was obtained in patients who died, but no significant differences compared to those who did not die were observed. C-reactive protein and procalcitonin showed increased values in most patients. Conclusions: The findings of this study are related to others where it is concluded that presepsin is a good marker of sepsis with an important prognostic value and greater specificity than other traditional biomarkers. (AU)

Evaluación de la coloración de Albert para la identificación de Corynebacterium spp. en flujo vaginal / Evaluation of Albert´s staining technique for Corynebacterium spp. in vaginal swabs

Introducción: la detección del género Corynebacterium en flujo vaginal representa un reto para el estudio de su posible papel patogénico en el tracto genital femenino. La coloración de Gram es la técnica recomendada para la detección de corinebacterias en muestras clínicas; no obstante, algunas características biológicas de estas bacterias dificultan la identificación por medio de esta. Objetivo: evaluar el desempeño de la coloración de Albert para la identificación de Corynebacterium spp. en muestras de flujo vaginal. Materiales y métodos: se evaluó la tinción de Albert como prueba diagnóstica para la identificación de Corynebacterium spp. en 451 flujos vaginales en comparación de la coloración de Gram. Se calculó la sensibilidad, la especificidad, los valores predictivos, las razones de verosimilitud y el índice J de Youden con el software Epidat 3.1. Resultados: la coloración de Albert presentó sensibilidad y especificidad de 61,5% y 74,6%, respectivamente, valor predictivo positivo de 78,3%, valor predictivo negativo de 56,5%, razón de verosimilitud positiva de 2,4 y negativa de 0,5 y un Índice de Youden de 0,4. Conclusiones: la tinción de Albert no mostró un mejor rendimiento que la coloración de Gram en la identificación del género Corynebacterium en muestras de flujo vaginal. Por lo tanto, se recomienda el uso en conjunto de las coloraciones de Gram y Albert para la identificación de corinebacterias en flujo vaginal. (AU)

Introduction: The detection of Corynebacterium genus in vaginal discharge represents a challenge for the study of its possible pathogenic role in the female genital tract. Gram's stain is recommended for corynebacteria detection in clinical samples, however, some biological characteristics of these bacteria difficult their identification by this technique. Objetive: to evaluate Albert's stain performans to identify Corynebacterium spp. in vaginal discharge. Materials and methods: Albert's stain was evaluated as a diagnostic test for the identification of Corynebacterium spp. in 451 vaginal swabs in comparison to Gram's stain. Sensitivity, specificity, predictive values, likelihood ratio, as well as Youden's J index were calculated using Epidat software 3.1 version. Results: Albert's stain had a sensitivity and specificity of 61.5% and 74.6%, respectively, positive predictive value of 78.3 %, negative predictive value of 56.5 %, positive likelihood ratio of 2.4 and negative likelihood ratio of 0.5, as well as Youden index of 0.4. Conclusions: Albert's stain did not show better performance than Gram's stain for identification of corynebacteria in vaginal swabs. Thereforeit is recommended the concomitant use of the Gram and Albert stains for the identification of corynebacteria in vaginal discharge. (AU)

Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease / Diversidad genética del virus de la hepatitis B y mutaciones asociadas con carcinoma hepatocelular en pacientes de Venezuela, con diferentes estados de la enfermedad del hígado

Globally, about 50% of liver cancer originates as a result of long term infection with hepatitis B virus (HBV), and some genotypes and mutations have been associated with an increased severity of infection. The aim of this study was to evaluate the genetic diversity of HBV in patients from Venezuela, with chronic infection, cirrhosis and hepatocellular carcinoma (HCC) and to compare the occurrence of mutations in all patient groups. Samples from patients with different pathologies of the liver, associated with HBV infection, were collected. The HBV S region was analyzed for genotype determination and, when available, the whole genome sequence was examined for mutations analysis. Genotype F was the most common genotype (87%). While the HBV subgenotype F3 was the most frequent genotype in the whole group of samples (44%), the subgenotype F2 predominated in HCC patients (56%). Mutations were more common in HCC and cirrhosis cases (p=0.01). The A1762T mutation was significantly associated with the advanced stage of liver disease (p=0.008). Additionally, mutations were more common in early stages of liver disease in HBV subgenotype F2- infected patients, and a significant association between this subgenotype and the emergence of T1753C, A1762T, A1762T/G1764A (p=0.04) and C1773T (p=0.001) mutations in chronic patients was found, when compared to the HBV subgenotype F3. By comparing F2 with all other HBV subgenotypes, a positive association for the three basal core promoter (BCP) mutants (A1762T, A1762T/G1764A p=0.01, G1764A p=0.04) was found. These results suggest that the HBV subgenotype F2 might be associated to more severe forms of liver disease in comparison with the HBV subgenotype F3.

Mundialmente, alrededor del 50% del cáncer de hígado se origina como consecuencia de la infección a largo plazo con el virus de la hepatitis B (VHB), y algunos genotipos y mutaciones han sido asociados con severidad incrementada de la infección. El objetivo de este estudio fue evaluar la diversidad genética del VHB en pacientes de Venezuela con infección crónica, cirrosis y carcinoma hepatocelular (CHC) y comparar la ocurrencia de mutaciones en los tres grupos de pacientes. Se reunieron muestras de pacientes con diferentes patologías de la enfermedad del hígado asociada a la infección por VHB. La región S del VHB fue analizada para la determinación del genotipo y cuando estuvo disponible, la secuencia del genoma completo fue examinada para análisis de mutaciones. El genotipo F de VHB fue el más frecuente (87%). Mientras que el F3 fue el subgenotipo más encontrado en el grupo completo de muestras (44%), el F2 fue predominante en pacientes con CHC (56%). Las mutaciones fueron más comunes en casos de pacientes con cirrosis y CHC (p=0,01). La mutación A1762T estuvo asociada significativamente con estado avanzado de la enfermedad del hígado (p=0,008). Adicionalmente, las mutaciones fueron más comunes en estados tempranos de la enfermedad del hígado en pacientes infectados con el subgenotipo F2, encontrándose una asociación significativa entre este subgenotipo y la ocurrencia de las mutaciones T1753C, A1762T, A1762T/ G1764A (p=0,04) y C1773T (p=0,001) en pacientes crónicos, en comparación con el subgenotipo F3. Por otro lado, al comparar F2 con los demás subgenotipos de VHB, se encontró una asociación positiva para las tres mutantes del promotor basal de la cápside (PBC) (A1762T, A1762T/G1764A p=0,01, G1764A p=0,04). Estos resultados sugieren que el subgenotipo F2 de VHB puede estar asociado a formas más severas de la enfermedad del hígado en comparación al subgenotipo F3.

Relationship between nursing care quality, nurse staffing, nurse job satisfaction, nurse practice environment, and burnout: literature review.

The purpose of this literature review is to explore the relationship between nurse staffing, nurse job satisfaction, nurse practice environment, burnout, and nursing care quality through a consideration of what is meant by perceptions of nursing care quality. Different people define nursing care quality in many ways. It is complex, multi-faceted and multi-dimensional, and attempts to assess, monitor, evaluate and improve nursing care quality have evolved over a number of years. Of particular interest is the way in which changes in nurse staffing, nurse job satisfaction, nurse practice environment, and burnout may affect the quality of nursing care delivery. A search was conducted using the CINAHL, Medline and Embase databases, HINARI, Science Direct, Google, and PubMed. The terms searched included quality of health care; nursing care quality; nurse job satisfaction; nurse practice environment; burnout; and nurse staffing. Papers were included for their relevance to the field of enquiry. The original search was conducted in 2003 and updated in 2004. Quality of care is a complex, multi-dimensional concept, which presents researchers with a challenge when attempting to evaluate it. Many different tools have assessed nursing care quality. In addition, the review found that there were relationships between nurse staffing, nurse job satisfaction, nurse practice environment, burnout, and nursing care qualit.

Molecular identification and genotyping of Streptococcus mutans from saliva samples of children in Medellin, Colombia / Identificación molecular y genotipificación de Streptococcus mutansde muestras de saliva de niños de Medellín, Colombia

Abstract Introduction and objective: Tooth decay is one of the most prevalent infectious diseases of the oral cavity. The aim of this study was to determine the prevalence of Streptoccocus mutans and its genotypes in saliva samples from 6 and 7 year old children with and without dental caries. Materials and methods: Forty seven saliva samples were obtained from 6-7 year-old children, randomly selected from a Public School in Medellin, Colombia. Oral examinations in order to determine the DMF-T Index (Decay, Missing and Filling Teeth) were carried out. Isolates were identified by the Streptoccocus sobrinus and Streptococcus mutans PCR, API 20STREP and 16S rRNA sequence analysis. Genotypes c, e, f and k were detected by PCR. Results: Prevalence of S. mutanswas 14.9%. Of the 47 saliva samples, 57.4% (27) corresponded to children with dental caries, and 8.5% (4) were positive for S. mutans genotype c, 2.1% (1 each) genotype f genotype k, and genotype cand k, respectively. Conclusion: Prevalence of S. mutanswas lower than in previous studies of Colombian children with similar demographic characteristics. Streptoccocusmutans'genotype c, fand kwere found in children with caries but not in the group without caries. This is the first report of S. mutans genotype kin Colombia; this genotype requires further study to clarify its relation with dental caries and cardiovascular disease in Colombia.

Resumen Introducción y objetivo: La caries dental es una de las enfermedades infecciosas de la cavidad oral más comunes en el mundo. El objetivo de este estudio fue determinar la prevalencia de Streptococcus mutansy sus genotipos en muestras de saliva de niños de 6 y 7 años, con y sin caries dental. Materiales y métodos: Cuarenta y siete (47) muestras de saliva fueron obtenidas de niños de 6-7 años, seleccionados aleatoriamente de una escuela pública en Medellín, Colombia. Se realizaron evaluaciones orales para determinar el índice COP-D (número de dientes permanentes cariados, obturados y perdidos). Los aislamientos fueron identificados mediante PCR para diferenciación de S. sobrinusy S. mutans, API-20STREP y análisis de ARNr 16S. Se determinaron mediante PCR los genotipos c e, fy ken las cepas identificadas como S. mutans. Resultados: La prevalencia de S. mutansfue 14,9%. De las 47 muestras de saliva, 57,4% (27) correspondieron a niños con caries dental, y 8,5 % (4), fueron positivas para S. mutans genotipo c, 2,1 % (1 cada una) genotipo f genotipo ky genotipo cy k, respectivamente. Conclusión: La prevalencia de S. mutansfue menor que la reportada en estudios previos de niños colombianos con características demográficas similares. Se encontró presencia de genotipos c, fy kde S. mutansen niños con caries dental, pero no en el grupo de niños sin caries dental. Este es el primer estudio en reportar la presencia del genotipo ken Colombia. Es necesario realizar más investigaciones en nuestro país para aclarar la relación de S. mutans genotipo k con caries dental y enfermedad cardiovascular.

Can the Perinatal Information System in Peru be used to measure the proportion of adverse birth outcomes attributable to maternal syphilis infection? / ¿Se puede utilizar el Sistema Informático Perinatal del Perú para medir la proporción de resultados adversos del nacimiento atribuibles a sífilis materna?

OBJECTIVE: To describe the capacity of Peru's Perinatal Information System (Sistema Informático Perinatal, SIP) to provide estimates for monitoring the proportion of stillbirths and other adverse birth outcomes attributable to maternal syphilis. METHODS: A descriptive study was conducted to assess the quality and completeness of SIP data from six Peruvian public hospitals that used the SIP continuously from 2000 - 2010 and had maternal syphilis prevalence of at least 0.5% during that period. In-depth interviews were conducted with Peruvian stakeholders about their experiences using the SIP. RESULTS: Information was found on 123 575 births from 2000 - 2010 and syphilis test results were available for 99 840 births. Among those 99 840 births, there were 1 075 maternal syphilis infections (1.1%) and 619 stillbirths (0.62%). Among women with syphilis infection in pregnancy, 1.7% had a stillbirth, compared to 0.6% of women without syphilis infection. Much of the information needed to estimate the proportion of stillbirths attributable to maternal syphilis was available in the SIP, with the exception of syphilis treatment information, which was not collected. However, SIP data collection is complex and time-consuming for clinicians. Data were unlinked across hospitals and not routinely used or quality-checked. Despite these limitations, the SIP data examined were complete and valid; in 98% of records, information on whether or not the infant was stillborn was the same in both the SIP and clinical charts. Nearly 89% of women had the same syphilis test result in clinical charts and the SIP. CONCLUSIONS: The large number of syphilis infections reported in Peru's SIP and the ability to link maternal characteristics to newborn outcomes make the system potentially useful for monitoring the proportion of stillbirths attributable to congenital syphilis in Peru. To ensure good data quality and sustainability of Peru's SIP, data collection should be simplified and information should be continually quality-checked and used for the benefit of participating facilities.

OBJETIVO: Describir la capacidad del Sistema Informático Perinatal (SIP) del Perú para proporcionar estimaciones que permitan vigilar la proporción de mortinatos y otros resultados adversos del nacimiento atribuibles a sífilis materna. MÉTODOS: Se llevó a cabo un estudio descriptivo para evaluar la calidad y la integridad de los datos del SIP correspondientes a seis hospitales públicos peruanos que utilizaron el SIP de forma continuada del 2000 al 2010, y presentaron una prevalencia de sífilis materna de como mínimo 0,5% durante ese período. Se realizaron entrevistas exhaustivas con interesados directos de Perú acerca de sus experiencias con el uso del SIP. RESULTADOS: Se obtuvo información sobre 123 575 nacimientos ocurridos del 2000 al 2010 y se dispuso de resultados de pruebas serológicas de sífilis correspondientes a 99 840 nacimientos. Se produjeron 1 075 casos de sífilis materna (1,1%) y 619 mortinatos (0,62%). El 1,7% de las mujeres con sífilis gestacional tuvieron un mortinato, en comparación con el 0,6% de las mujeres sin infección sifilítica. En el SIP se disponía de gran parte de la información necesaria para calcular la proporción de mortinatos atribuibles a sífilis materna, a excepción de la información sobre el tratamiento de la sífilis, que no se recopiló. Sin embargo, la recopilación de datos del SIP es compleja y exige a los médicos clínicos dedicar tiempo. Los datos de los diferentes hospitales no estaban vinculados, no se utilizaban habitualmente ni se sometían a controles de calidad. A pesar de estas limitaciones, los datos del SIP analizados estaban completos y eran válidos; en 98% de los registros, la información sobre si se trataba o no de un mortinato coincidía entre el SIP y las historias clínicas. En casi 89% de las mujeres los resultados de las pruebas serológicas de sífilis eran los mismos en las historias clínicas y el SIP. CONCLUSIONES: El gran número de infecciones sifilíticas notificadas en el SIP del Perú y la capacidad de vincular las características maternas con los resultados de los recién nacidos hacen que el sistema sea potencialmente útil para vigilar la proporción de mortinatos atribuibles a sífilis congénita en Perú. Con objeto de garantizar la buena calidad de los datos y la sostenibilidad del SIP en Perú, es preciso simplificar la recopilación de datos y mantener un control permanente de la calidad de la información, que debe utilizarse en beneficio de los establecimientos participantes.

Genótipos de vírus de papiloma humano em carcinoma de células escamosas de cabeça e pescoço na Colômbia / Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia

Estimar a prevalência de tipos do vírus de papiloma humano (HPV) em câncer de cabeça e pescoço (CCP) é relevante para se prever o impacto da vacina contra o HPV. OBJETIVO: Estimar a prevalência global, por gênero e idade, do vírus do HPV em CCP. MÉTODO: Estudo transversal, retrospectivo envolvendo quatro laboratórios de patologia de Medellín, Colômbia. O exame utilizado foi o PCR GP5+/6+ e hibridização reversa. Além disso, os HPV 16 e 18 foram identificados utilizando-se PCR específica para esses tipos. RESULTADOS: Foram incluídos 175 casos primários de CCP, consecutivamente diagnosticados entre 1999 e 2008, com diagnóstico confirmado e DNA amplificado. A prevalência de HPV foi de 18,9%. O HPV foi encontrado em 23,9%, 17,5% e 13,3% dos casos de cavidade oral, laringe e orofaringe, respectivamente. Entre os casos de VPH+, 82% foram HPV 16 e 18% HPV18. A maioria dos casos foi de pessoas do sexo masculino. Nos homens, a idade de diagnóstico foi menor do que nas mulheres, principalmente naqueles de acometimento na cavidade oral. CONCLUSÃO: Os HPV 16 e 18 foram encontrados em quase 20% desses casos de CCP. O impacto da vacinação contra o HPV para a prevenção desse câncer na população merece maiores estudos.

Estimating the type-specific prevalence of human papillomavirus (HPV) in head and neck cancer (HNSCC) is helpful in predicting the impact of HPV immunization. OBJECTIVE: To estimate the overall prevalence, and gender and age-specific prevalence of HPV in HNSCC. METHOD: This cross sectional retrospective study was carried out in four pathology laboratories of Medellin, Colombia. HPV testing was performed by GP5+/6+ PCR-based RLB and HPV 16 and 18 type-specific PCR. RESULTS: 175 primary HNSCC cases consecutively diagnosed between 1999 and 2008 with confirmed diagnosis and amplifiable DNA were included. Overall HPV prevalence was 18.9%. HPV was found in 23.9%, 17.5% and 13.3% of the oral cavity, larynx and oropharynx cases respectively. Among HPV positive cases, 82% were HPV 16 and 18% were HPV 18. No other HPV genotypes were identified. Most patients were males. Male patients were younger that their female counterparts, particularly in oral cavity cancer cases. CONCLUSION: HPV 16 and 18 genotypes were found in nearly 20% of HNSCC cases in Colombian patients. The impact of HPV vaccination for the prevention of HNSCC in this population deserves further evaluation.

High prevalence of hearing loss in Down syndrome at first year of life

<p><b>INTRODUCTION</b>Infants with Down syndrome (DS) are at higher risk of hearing loss (HL). Normal hearing at one year of age plays an important part in language development. An audit was conducted to determine the impact of the newborn hearing screening program on the incidence, type and timing of diagnosis of HL during first year of life.</p><p><b>MATERIALS AND METHODS</b>Infants with DS were scheduled for Universal Newborn Hearing Screening (UNHS) within 4 weeks of life. If they passed, they had a high-risk screen at 3 to 6 months. They were referred to the otolaryngology department if they did not pass the UNHS or the high-risk screen. Information was obtained from the computerised data tracking system and case notes. Infants born from April 2002 to January 2005 and referred to the DS clinic of our hospital were analysed.</p><p><b>RESULTS</b>Thirty-seven (82.2%) of 45 infants underwent UNHS, of which 12 (32.4%) infants did not pass. Of remaining 33 infants, 27 had high-risk screen done of which 14 (51.8%) did not pass. Twenty-eight infants were referred to the ear, nose, throat (ENT) clinic: 12 from UNHS, 14 from high-risk screens and 2 from the DS clinic. Eleven (39.2%) defaulted follow-up. Fourteen (82.3%) of 17 infants who attended the ENT Clinic had HL. Twelve (85.7%) were conductive, and 2 (14.2%) mixed. Nine (64.2%) had mild-moderate HL and 3 (21%) had severe HL. The mean age of diagnosis was 6.6 ± 3.3 months. All were treated medically, plus surgically if indicated. By 12 months of age, the hearing had normalised in 4 (28.6%) infants and remained the same in 3 (21.4%). Five (35.7%) defaulted follow-up. Thirty-five out of 45 (77.8%) underwent complete hearing screen in the first year of life (UNHS & High-risk screen). Six out of 45 (13.3%) had incomplete screening. Fourteen out of 41 (34.1%) had HL of varying degrees. Four out of 45 (8.8%) did not have any audiological assessment in first year of life.</p><p><b>CONCLUSION</b>The incidence of HL in the first year of life was high (34.1%). Eighty-five percent were conductive with 64.2% in mild-moderate range. One third of infants hearing normalized after treatment, one third remained unaltered and one third of infants did not attend follow-up. An aggressive approach involving early screening after birth and continued surveillance and early referral to appropriate agencies are essential for establishing timely diagnosis and treatment. Measures to reduce the high default rate during long-term follow-up are needed. Parent education and integrated multidisciplinary follow-up clinic may be useful.</p>

Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1 / Journal of the Korean Cancer Association, 대한암학회지

It has long been assumed that the immune system plays a role in tumor eradication, however, scant clinical evidence exists to support that hypothesis. In recent years, as the immune system and its specific effector cells are better defined, convincing data supporting immune surveillance is emerging. Several studies have shown that an "immune signature" in the tumor microenvironment is associated with a superior outcome in a variety of cancer types. Moreover, studies have suggested that T cells found in high density within the tumor parenchyma are also correlated with a survival benefit. The type of adaptive immune response implicated in improved cancer outcomes is a type 1 response. That is, adaptive immunity associated with T cells that secrete pro-inflammatory cytokines, such as IFN-gamma, which can not only support a proliferative antigen specific T cell response but also enhance "cross priming" by activating antigen presenting cells local to the tumor site. There are many methods available that will allow the development of clinical reagents designed to stimulate Th1 immunity; either by in vitro or in vivo manipulation. Clinical trials of a variety of immunotherapeutic strategies indicate that the generation of tumor antigen specific Th1 may be beneficial in inhibiting the growth of common solid tumors.

Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil

A survey was conducted among the hemodialysis units of the city of Campo Grande, located in the state of Mato Grosso do Sul in the Mid-west region of Brazil, with the aim of investigating the prevalence, risk factors, and genotypes of hepatitis C virus (HCV) infection. A total of 163 patients were interviewed in five dialysis units. Serum samples were screened for anti-HCV. Positive samples were tested for HCV RNA and genotyped. The prevalence of anti-HCV was 11 percent (95 percent CI: 6.8-17.1). A history of transfusion with blood that was not screened for anti-HCV and length of time on hemodialysis were associated with HCV infection. HCV RNA was detected in 12 samples: ten were of genotype 1, subtypes 1a (75 percent) and 1b (8.3 percent), and two were of genotype 3, subtype 3a (16.7 percent).

Transmission analysis of candidate genes for nonsyndromic oral clefts in Brazilian parent-child triads with recurrence

Cleft lip and/or palate (CL/P) is a major congenital defect with complex etiology, including multiple genetic and environmental factors. Approximately two thirds of the cases are not accompanied by other anomalies and are called nonsyndromic (NS). In the present study, we performed transmission distortion analysis of the MSX1-CA, TGFB3-CA and MTHFR-C677T polymorphisms in 60 parent-child triads, in which the NS-CL/P affected child had at least one affected parent. No association with genes MSX1 or TGFB3 was found, but the results were suggestive of an association of the MTHFR-C677T polymorphism with NS-CL/P.

Célula precursora de sangue de cordäo umbilical humano: viabilidade para transplantes e terapia gênica / Umbilical cord blood: a new source of hematopoietic cells for transplantation and gene therapy

O transplante de células precursoras de linhagem hematopoiética é utilizado como importante arma terapêutica nas neoplasias hematológicas e doenças genéticas. A principal fonte destas células tem sido, há alguns anos, a medula óssea de doadores voluntários. Entretanto, dada à dificuldade em se encontrar doador HLA compatível, houve necessidade de se procurar outros tipos de fonte. Nos últimos 14 anos, o sangue de cordäo umbilical vem sendo analisado como possível fonte alternativa. Apresenta como vantagem, em relaçäo à medula óssea, ser material facilmente obtido e manipulado com facilidade. O sangue de cordäo é extremamente rico em células precursoras, fornecendo em cultura, número de colônias de CFU-GM suficientes para recuperaçäo da linhagem hematopoiética. Outra vantagem é a baixa incidência de doença enxerto versus hospedeiro (GVHD) quando utilizado em transplante. Tanto a criopreservaçäo quanto o tempo de congelamento näo alteraram o número dos vários tipos de linfócitos do sangue de cordäo. Quanto à sua aplicaçäo na prática médica, recentemente dois autores demonstraram a sua viabilidade em transplantes em situaçöes clínicas de grande risco. Kurtzberg et al (1996) e Wagner et al (1996) transplantaram pacientes utilizando sangue de cordäo de indivíduos näo relacionados, alguns incompatíveis até a três antígenos HLA, obtendo bons resultados. O sangue de cordäo pode também ser utilizado em terapia gênica. De acordo com dados de literatura, suas células apresentam maior capacidade de proliferaçäo que as da medula, podendo ser eficientemente infectadas com retrovírus, apresentando alto nível de expressäo da seqüência introduzida. Resultados recentemente obtidos em nosso laboratório demonstraram que houve melhor crescimento celular quando se utilizou a metilcelulose como meio, possibilitando a repicagem das colônicas para replaqueamentos e utilizaçäo em cultura de longa duraçäo. De acordo com os dados da literatura publicados ao longo destes anos, o sangue de cordäo será, no futuro, a fonte de células precrursoras de linhagem hematopoiética mais utilizada em terapia gênica e transplantes.

A influência do sexo, duraçäo, severidade e denominaçäo de sintomas sobre o comportamento de adaptaçäo à doença / The influence of sex, duration, severity and naming of symptoms on illness coping behaviors

Identifica fatores subjacentes a estratégias de adaptaçäo empreendidas por indivíduos hipotéticamente ameaçados por episódios de doenças e investiga, em uma amostra de 698 estudantes universitários, os efeitos do sexo, da duraçäo, da severidade e da ambigüidade de ameaças de doença, sobre as estratégias de adaptaçäo, as reaçöes emocionais e o uso de recursos médicos. Independentemente do tipo de episódio, as mulheres diferem dos homens na indicaçäo de maior probabilidade de recorrerem a mudança de dieta. Severidade dos sintomas provoca diferenças na antecipaçäo de mais açöes de adaptaçäo, reaçöes emocionais mais negativas e maior probabilidade de se recorrer a serviços médicos. Efeitos de duraçäo e severidade dos sintomas interagem com açöes de negaçäo e busca de apoio. Näo há influência da ambigüidade de sintomas. Esses resultados indicam a necessidade de se considerar percepçöes e interpretaçöes das pessoas quando do estudo da maneira como se adaptam a sintomas de doenças